NCT04802577

Brief Summary

Fatigue is a common clinical finding in Primary Sjögren's syndrome (PSS). In PSS, there is not enough data about the conditions in which fatigue develops and which clinical conditions the disease is associated with. This study was aimed to determine the level of fatigue in Primary Sjögren syndrome and to investigate the factors affecting the level of fatigue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 14, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
Last Updated

December 13, 2021

Status Verified

November 1, 2021

Enrollment Period

7 months

First QC Date

March 14, 2021

Last Update Submit

November 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • FACIT-F

    FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATİQUE

    day 1

Secondary Outcomes (4)

  • BDI

    day 1

  • BAI

    day 1

  • ISS

    day 1

  • PDQ

    day 1

Study Arms (2)

Primary Sjögren's syndrome

The patient's diagnosed with Primary Sjögren's according to 2016 ACR/EULAR classification criteria

Diagnostic Test: FACT-F questionnaireDiagnostic Test: Beck Depression InventoryDiagnostic Test: Beck Anxiety InventoryDiagnostic Test: Insomnia severity index.Other: ESSPRIOther: ESSDAIOther: Pain Detect Questionnaire

Healthy Controls

Healthy hospital workers without any chronic disease

Diagnostic Test: FACT-F questionnaireDiagnostic Test: Beck Depression InventoryDiagnostic Test: Beck Anxiety InventoryDiagnostic Test: Insomnia severity index.Other: Pain Detect Questionnaire

Interventions

FACT-F questionnaireDIAGNOSTIC_TEST

The questionnaire, based on patient report outcome data in which the presence of fatique is investigated in participants.

Healthy ControlsPrimary Sjögren's syndrome

The questionnaire, based on patient report outcome data in which the presence of depression is investigated in participants.

Healthy ControlsPrimary Sjögren's syndrome
Beck Anxiety InventoryDIAGNOSTIC_TEST

The questionnaire, based on patient report outcome data in which the presence of anxiety is investigated in participants.

Healthy ControlsPrimary Sjögren's syndrome

The questionnaire, based on patient report outcome data in which the presence of insomnia is investigated in participants.

Healthy ControlsPrimary Sjögren's syndrome
ESSPRIOTHER

The questionnaire, based on patient report outcome data in which the severity of Sjögren's syndrome is investigated in participants.

Primary Sjögren's syndrome
ESSDAIOTHER

Activity scale in which the activity of Sjögren's syndrome is evaluated based on the laboratory and imaging tests of the patients and the examination findings of the evaluator.

Primary Sjögren's syndrome

The questionnaire, based on patient report outcome data in which the severity and extent of pain in the body are investigated in participants.

Healthy ControlsPrimary Sjögren's syndrome

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Volunteers who were followed up with a diagnosis of PSS in the center where the study was conducted and met the inclusion and exclusion criteria.

You may qualify if:

  • Patients diagnosed with PSS according to the 2016 ACR / EULAR criteria
  • Healthy hospital staff

You may not qualify if:

  • Pregnant women
  • Cancer patients
  • Those with other connective tissue diseases other than PSS
  • Multiple sclerosis patients
  • Chronic obstructive pulmonary disease
  • Those with heart failure and adrenal insufficiency
  • Those with renal failure: GFR \<60 ml/min
  • Anemia: Hemoglobin \<11 g / dl in women, hemoglobin \<12 g / dl in men
  • Hypothyroidism: TSH \>5 mu / L
  • Those with electrolyte disturbance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koray Ayar

Yıldırım, Bursa, 16310, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Erythrocyte sedimentation rate, CRP, routine biochemical tests, and hemogram

MeSH Terms

Conditions

Sjogren's SyndromeFatigueSomatoform DisordersDepressionAnxiety DisordersFibromyalgia

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesXerostomiaSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehaviorMuscular DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Koray Ayar, M.D.

    Univesity of Health Science, Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 14, 2021

First Posted

March 17, 2021

Study Start

January 4, 2021

Primary Completion

July 30, 2021

Study Completion

July 30, 2021

Last Updated

December 13, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations